Search

Your search keyword '"Schved, Jean-François"' showing total 414 results

Search Constraints

Start Over You searched for: Author "Schved, Jean-François" Remove constraint Author: "Schved, Jean-François"
414 results on '"Schved, Jean-François"'

Search Results

1. Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A

2. Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database

3. Surgery in rare bleeding disorders: the prospective MARACHI study

5. Compliance with Early Long-Term Prophylaxis Guidelines for Severe Hemophilia A

8. Position du GIHP sur les tests viscoélastiques : quelle place pour quelle indication en situation hémorragique ?

9. Management of bleeding and emergency invasive procedures in patients on dabigatran: Updated guidelines from the French Working Group on Perioperative Haemostasis (GIHP) – September 2016

11. Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study

12. Choice of factor VIII/IX regimen in adolescents and young adults with severe or moderately severe haemophilia. A French national observational study (ORTHem 15-25)

14. Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) – September 2015

15. Gestion des anticoagulants oraux directs pour la chirurgie et les actes invasifs programmés : propositions réactualisées du Groupe d’intérêt en hémostase périopératoire (GIHP) – septembre 2015

17. APOLD1 loss causes endothelial dysfunction involving cell junctions, cytoskeletal architecture, and Weibel-Palade bodies, while disrupting hemostasis

20. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) – March 2013

23. APOLD1 loss causes endothelial dysfunction involving cell junctions, cytoskeletal architecture, and Weibel-Palade bodies, while disrupting hemostasis

27. Cover Image

28. The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors

29. PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors

32. Compliance with Early Long-Term Prophylaxis Guidelines for Severe Hemophilia A

33. Occupational integration of adults with severe haemophilia (INTHEMO): A study based on the FranceCoag registry.

34. PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.

37. Liste des Collaborateurs

40. Long-Term Antithrombotic Treatments Prescribed for Cardiovascular Diseases in Patients with Hemophilia: Results from the French Registry

Catalog

Books, media, physical & digital resources